BLUE logo

Bluebird Bio (BLUE) Current Assets

Annual Current Assets

$281.69 M
+$78.11 M+38.37%

December 31, 2023


Summary


Performance

BLUE Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBLUEbalance sheetmetrics:

Quarterly Current Assets

$150.81 M
-$52.70 M-25.90%

September 30, 2024


Summary


Performance

BLUE Quarterly Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBLUEbalance sheetmetrics:

Current Assets Formula

Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets

BLUE Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+38.4%-44.5%
3 y3 years-76.8%-25.9%
5 y5 years-80.2%-87.6%

BLUE Current Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-16.3%+38.4%-57.0%at low
5 y5-year-76.8%+38.4%-90.7%at low
alltimeall time-80.2%+839.6%-91.3%+122.5%

Bluebird Bio Current Assets History

DateAnnualQuarterly
Sep 2024
-
$150.81 M(-25.9%)
Jun 2024
-
$203.52 M(-25.1%)
Mar 2024
-
$271.60 M(-3.6%)
Dec 2023
$337.48 M(-7.9%)
$281.69 M(+14.0%)
Sep 2023
-
$247.08 M(-14.2%)
Jun 2023
-
$287.98 M(-18.0%)
Mar 2023
-
$351.07 M(+72.5%)
Dec 2022
$366.24 M(+42.4%)
$203.57 M(+26.9%)
Sep 2022
-
$160.44 M(-4.2%)
Jun 2022
-
$167.46 M(-34.3%)
Mar 2022
-
$254.92 M(-24.2%)
Dec 2021
$257.27 M(-54.5%)
$336.52 M(-59.6%)
Sep 2021
-
$832.33 M(-7.9%)
Jun 2021
-
$903.53 M(-17.7%)
Mar 2021
-
$1.10 B(-9.7%)
Dec 2020
$565.72 M(-1.7%)
$1.22 B(-6.0%)
Sep 2020
-
$1.29 B(-19.8%)
Jun 2020
-
$1.61 B(+66.8%)
Mar 2020
-
$967.47 M(-16.0%)
Dec 2019
$575.25 M(-30.2%)
$1.15 B(-5.6%)
Sep 2019
-
$1.22 B(-6.2%)
Jun 2019
-
$1.30 B(-4.7%)
Mar 2019
-
$1.37 B(-3.8%)
Dec 2018
$823.85 M
$1.42 B(-17.8%)
DateAnnualQuarterly
Sep 2018
-
$1.73 B(+56.0%)
Jun 2018
-
$1.11 B(-5.0%)
Mar 2018
-
$1.16 B(-12.0%)
Dec 2017
$577.80 M(+46.7%)
$1.32 B(+74.3%)
Sep 2017
-
$758.71 M(-32.2%)
Jun 2017
-
$1.12 B(+67.6%)
Mar 2017
-
$667.31 M(-7.9%)
Dec 2016
$393.91 M(-17.7%)
$724.21 M(+19.0%)
Sep 2016
-
$608.84 M(+4.5%)
Jun 2016
-
$582.89 M(+3.9%)
Mar 2016
-
$560.97 M(+7.1%)
Dec 2015
$478.37 M(+523.3%)
$523.97 M(-26.5%)
Sep 2015
-
$713.15 M(-12.5%)
Jun 2015
-
$815.45 M(+139.3%)
Mar 2015
-
$340.84 M(-29.0%)
Dec 2014
$76.75 M(+518.8%)
$479.99 M(+114.9%)
Sep 2014
-
$223.32 M(+22.1%)
Jun 2014
-
$182.87 M(-6.7%)
Mar 2014
-
$195.92 M(-7.6%)
Dec 2013
$12.40 M(+706.4%)
$211.99 M(-4.3%)
Sep 2013
-
$221.47 M(-3.9%)
Jun 2013
-
$230.53 M(+70.6%)
Mar 2013
-
$135.09 M(+99.3%)
Dec 2012
$1.54 M(+64.0%)
$67.78 M
Dec 2011
$938.00 K
-

FAQ

  • What is bluebird bio annual total current assets?
  • What is the all time high annual current assets for bluebird bio?
  • What is bluebird bio annual current assets year-on-year change?
  • What is bluebird bio quarterly total current assets?
  • What is the all time high quarterly current assets for bluebird bio?
  • What is bluebird bio quarterly current assets year-on-year change?

What is bluebird bio annual total current assets?

The current annual current assets of BLUE is $281.69 M

What is the all time high annual current assets for bluebird bio?

bluebird bio all-time high annual total current assets is $1.42 B

What is bluebird bio annual current assets year-on-year change?

Over the past year, BLUE annual total current assets has changed by +$78.11 M (+38.37%)

What is bluebird bio quarterly total current assets?

The current quarterly current assets of BLUE is $150.81 M

What is the all time high quarterly current assets for bluebird bio?

bluebird bio all-time high quarterly total current assets is $1.73 B

What is bluebird bio quarterly current assets year-on-year change?

Over the past year, BLUE quarterly total current assets has changed by -$120.79 M (-44.47%)